OUR FOCUS
Perspective from founding scientist on an innovative solution that combines Alzheimer's treatment and prevention, brain repair, and anti-aging in a single therapeutic approach.
A powerhouse of innovation and early-stage therapeutic R&D for neurological disorders and aging. At preclinical stage and in stealth mode now, primed for a game-changing debut.
Single therapeutic, multiple indications. Learn more in our podcast above.
Many causes of dementia share a common feature: they trigger neuroinflammation and disrupt the delicate brain microenvironments. Our therapeutic strategies enable neurons to thrive amid these environmental challenges, by targeting a gatekeeper of these disease triggers.
We develop 1st-in-class therapeutics delivered via noninvasive nasal spray with unprecedented triple actions: curb brain degeneration, promote functional regeneration, and significantly delay aging. Learn the mechanisms in our podcast above.
We are powered by decades of combined expertise in neuroscience R&D, clinical trials, companion diagnostics, regulatory strategy, IP roadmap, AI application, and supported by accomplished industry leaders.
WHAT MAKES US UNIQUE
Meet our AI ambassadors for company announcements. Drop a line to connect with our team.
We integrate patient inputs into our drug development strategy. If you or your loved one is affected by age-related dementia, we'd love to hear from you!
If you are investors passionate about transforming dementia and aging care through groundbreaking innovation, we'd love to explore opportunities together!
For quicker response, message us on LinkedIn